摘要
分析150例平滑肌肿瘤的随访资料。46例LM中除1例死于其它原因外,余全部存活。104例LS术后逐年生存率为1年84.6%,2年69.2%,3年57.7%,4年53.8%,5年50.0%。LS预后与核分裂数、细胞形态、细胞密度及细胞异形性四项形态学指标均有关,其中核分裂数与预后关系最为密切。免疫组化检测结果显示:①PCNA及c-erbB-2的表达与LS预后有密切关系。②PCNA的表达与核分裂数、细胞形态及细胞异形性有关。③c-erbB-2的表达与核分裂数及细胞异形性有关。提示这二项检测方法是估计LS预后的可靠手段。
The follow-up data of 150 patients with smooth muscle tumors were analysed. Except one patients with leiomyomas survived.Of 104 leiomyosarcomas(LS)84.6%survived for 1 yrs,69.2% for 2yrs,57.7% for 3 yrs,53.8% for 4 yrs,and 50% for 5yrs after operation,respectively.The prognosis of LS are related with four morphology indexes,including mitotic figures,cellular polymorphism cellularity,and atypism.Mitotic figures were most related.Immunohistochemical staining Showed that: 1)the expression of PCNA as well as c-erbB-2 correlated closely with prognosis of LS,2)the expression of PCNA was associated with mitotic figore,0cellular polymorphism and atypism,3)the expression of c-erbB-2 corelated with mitotic figure and atypism.It is suggested that these two parameters may be used in the evaluation of prognosis of LS.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
1996年第8期576-579,共4页
Chinese Journal of Clinical Oncology
关键词
平滑肌肉瘤
形态学
癌基因产物
预后
Leiomyosarcoma Morphology Oncogen products Prognosis